We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 06, 2020

Uric Acid Predicts Long-Term Cardiovascular Risk in Type 2 Diabetes

Diabetes, Obesity & Metabolism

 

Additional Info

Diabetes, Obesity & Metabolism
Uric Acid Predicts Long-Term Cardiovascular Risk in Type 2 Diabetes But Does Not Mediate the Benefits of Fenofibrate: The FIELD Study
Diabetes Obes Metab 2020 Apr 03;[EPub Ahead of Print], JY Cao, B Waldman, R O'Connell, DR Sullivan, RS Scott, N Aryal, V Gebski, I Marschner, MR Taskinen, JR Simes, N McGill, AJ Jenkins, AC Keech

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading